STOCK TITAN

Scoggin Affiliates Disclose 0.01% Holding in Scienture Holdings (SCNX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Scoggin-affiliated investors report a small passive stake in Scienture Holdings Inc. The filing discloses that Scoggin International Fund Ltd., Scoggin Management LP, Scoggin GP LLC and individuals Curtis Schenker and Craig Effron each beneficially own 150,000 shares of Scienture common stock, representing 0.01% of the 16,131,180 shares outstanding cited in the filing. The reporting persons state the holdings were not acquired to influence control of the issuer and identify the relationships among the entities: Scoggin GP LLC is the general partner of Scoggin Management LP, which manages Scoggin International Fund Ltd., and Messrs. Schenker and Effron are co-managing members. Exhibits include a joint filing agreement and an Item 8 statement.

Positive

  • Transparent disclosure of beneficial ownership by fund, management entities, and individuals
  • Clear statement that holdings are not intended to influence control, consistent with a passive 13G filing
  • Relationship mapping between entities and individuals is explicitly disclosed (general partner, investment manager, co-managing members)

Negative

  • None.

Insights

TL;DR: Minor passive position unlikely to affect shareholder control or company strategy.

The disclosed 150,000-share positions equal roughly 0.01% of outstanding common stock, which is immaterial relative to total shares outstanding and unlikely to move markets or shift governance outcomes. The filer categorizes the holdings as passive and certifies they were not acquired to influence control, consistent with a Schedule 13G filing. For investors this is a routine ownership disclosure from an investment manager and related entities; it provides transparency about ownership but does not signal a strategic stake or activist intent.

TL;DR: Ownership structure and filing form indicate compliance and no group control.

The filing clarifies the chain of control among the reporting persons and shows shared voting/dispositive arrangements for the two individual reporting persons, which is appropriately disclosed. The use of Schedule 13G and the certification that holdings are not meant to influence control align with passive investor treatment under SEC rules. There are no indications of coalition activity or control claims requiring a Schedule 13D, so governance impact is negligible based on the disclosed facts.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The percentage of Common stock reported herein as being beneficially owned by the Reporting Persons reflects 16,131,180 shares of Common stock outstanding as of August 12, 2025, as set forth in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage of Common stock reported herein as being beneficially owned by the Reporting Persons reflects 16,131,180 shares of Common stock outstanding as of August 12, 2025, as set forth in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage of Common stock reported herein as being beneficially owned by the Reporting Persons reflects 16,131,180 shares of Common stock outstanding as of August 12, 2025, as set forth in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Comprised of shares of Common stock held by Scoggin International Fund Ltd. Curtis Schenker is a co-managing member of Scoggin GP LLC, which is the general partner of Scoggin Management LP, the investment manager of Scoggin International Fund Ltd. The percentage of Common stock reported herein as being beneficially owned by the Reporting Persons reflects 16,131,180 shares of Common stock outstanding as of August 12, 2025, as set forth in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Comprised of shares of Common stock held by Scoggin International Fund Ltd. Craig Effron is a co-managing member of Scoggin GP LLC, which is the general partner of Scoggin Management LP, the investment manager of Scoggin International Fund Ltd. The percentage of Common stock reported herein as being beneficially owned by the Reporting Persons reflects 16,131,180 shares of Common stock outstanding as of August 12, 2025, as set forth in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025.


SCHEDULE 13G



Scoggin International Fund Ltd.
Signature:/s/ Craig Effron
Name/Title:Craig Effron/Co-Managing Member
Date:08/20/2025
Scoggin Management LP
Signature:/s/ Craig Effron
Name/Title:Craig Effron/Co-Managing Member
Date:08/20/2025
Scoggin GP LLC
Signature:/s/ Craig Effron
Name/Title:Craig Effron/Co-Managing Member
Date:08/20/2025
Curtis Schenker
Signature:/s/ Curtis Schenker
Name/Title:Curtis Schenker
Date:08/20/2025
Craig Effron
Signature:/s/ Craig Effron
Name/Title:Craig Effron
Date:08/20/2025
Exhibit Information

Exhibit A. Joint Filing Agreement. Exhibit B. Item 8 Statement.

FAQ

What stake in Scienture Holdings (SCNX) did Scoggin report?

The reporting persons each beneficially own 150,000 shares, representing 0.01% of the 16,131,180 shares outstanding stated in the filing.

Which entities and individuals filed the Schedule 13G for SCNX?

Scoggin International Fund Ltd., Scoggin Management LP, Scoggin GP LLC, Curtis Schenker, and Craig Effron are the reporting persons named in the filing.

Does the filing indicate intent to influence control of Scienture?

No. The filing includes a certification that the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.

How are voting and dispositive powers allocated among the reporting persons?

Scoggin International Fund Ltd., Scoggin Management LP, and Scoggin GP LLC report sole voting and dispositive power over 150,000 shares; Curtis Schenker and Craig Effron report shared voting and dispositive power over 150,000 shares.

What exhibits accompany the Schedule 13G filing?

The filing lists Exhibit A: Joint Filing Agreement and Exhibit B: Item 8 Statement.
Scienture Holdings, Inc

NASDAQ:SCNX

SCNX Rankings

SCNX Latest News

SCNX Latest SEC Filings

SCNX Stock Data

21.24M
33.79M
25.78%
1.56%
0.67%
Pharmaceutical Retailers
Pharmaceutical Preparations
Link
United States
COMMACK